Hypoxia has been implicated as a crucial microenvironmental factor that induces cancer metastasis. We previously reported that hypoxia could promote gastric cancer (GC) metastasis, but the underlying mechanisms are not clear. Long noncoding RNAs (lncRNAs) have recently emerged as important regulators of carcinogenesis that act on multiple pathways. However, whether lncRNAs are involved in hypoxia-induced GC metastasis remains unknown. In this study, we investigated the differentially expressed lncRNAs resulting from hypoxia-induced GC and normoxia conditions using microarrays and validated our results through real-time quantitative polymerase chain reaction. We found an lncRNA, AK058003, that is upregulated by hypoxia. AK058003 is frequently upregulated in GC samples and promotes GC migration and invasion in vivo and in vitro. Furthermore, AK058003 can mediate the metastasis of hypoxia-induced GC cells. Next, we identified γ-synuclein (SNCG), which is a metastasis-related gene regulated by AK058003. In addition, we found that the expression of SNCG is positively correlated with that of AK058003 in the clinical GC samples used in our study. Furthermore, we found that the SNCG gene CpG island methylation was significantly increased in GC cells depleted of AK058003. Intriguingly, SNCG expression is also increased by hypoxia, and SNCG upregulation by AK058003 mediates hypoxia-induced GC cell metastasis. These results advance our understanding of the role of lncRNA-AK058003 as a regulator of hypoxia signaling, and this newly identified hypoxia/lncRNA-AK058003/SNCG pathway may help in the development of new therapeutics.
Introduction
Gastric cancer (GC) is one of the most common human cancers and the second leading cause of cancer-related mortality worldwide [1] . The major cause of death is metastasis, which greatly hinders treatment success [2] . Hypoxia is an important microenvironmental factor that induces such metastasis. In fact, hypoxic tumors are often aggressive and more likely to metastasize [3] . Therefore, investigating the underlying mechanisms of hypoxia-induced metastasis is critical. We have previously performed studies exploring the mechanism underlying GC pathogenesis under hypoxic stress, with a focus on protein-coding genes [4] [5] [6] . However, protein-coding genes account for less than 2% of the human genome, as most of the genome is transcribed into non-coding RNAs (ncRNAs) [7, 8] . Recently, long noncoding RNAs (lncRNAs) have been reported to be associated with hypoxia-induced cancer development [9] and to contribute to hypoxia-mediated HepatoCellular Carcinoma metastasis [10] .
LncRNAs have been identified as a new class of functional ncRNAs and have kindled our interest. lncRNAs are defined as transcripts of longer than 200 nucleotides without evident protein-coding function [11] . Few studies have implicated lncRNAs in various cancers [12, 13] , and several of the altered lncRNAs can result in the aberrant expression of nearby protein-coding genes, which may contribute to cancer development [14] [15] [16] . Studies have also demonstrated that lncRNAs play an important role in tumor development via various mechanisms, such as chromatin remodeling [17] , DNA methylation [18] , transcriptional regulation [19] , and DNA damage repair [14, 20] . All related processes play a pivotal role in malignant transformation and cancer treatment. However, the function of most lncRNAs in cancer remains a mystery, and lncRNA profiles in hypoxic GC and hypoxia-responsive gene networks remain unknown.
Prototypical lncRNAs have been shown to be overexpressed in subsets of cancers, to interact with epigenetic complexes [17] , to be recruited to DNA sequences as enhancers, and to regulate transcription [19, 21] and DNA methylation [18, 22] . To explore the role of lncRNAs in hypoxic GC, we identified a small number of lncRNAs and messenger RNAs (mRNAs) that are aberrantly expressed in GC under hypoxia compared with normoxia using microarrays. We also investigated the biological function of the hypoxia-upregulated AK058003 both in vivo and in vitro. The synuclein family consists of three distinct highly homologous genes, α-synuclein, β-synuclein, and γ-synuclein (SNCG), which have been well studied in connection with cancer [23] . Further analysis demonstrated that SNCG is overexpressed in several types of cancer [24] . In our study, the inhibition of lncRNA-AK058003 and SNCG was found to play an important role in hypoxia-induced metastasis and invasion, suggesting that manipulating new ncRNA functions can provide a therapeutic opportunity that is worth exploring.
Materials and Methods

Ethics Statement
For tissue specimens, signed informed consent was obtained from the patients who contributed dissected tissues. All GC cases were clinically and pathologically confirmed. The experimental procedures were approved by the Institutional Review Board of the Fourth Military Medical University and conformed to the Helsinki Declaration and local legislation. All animal experiments were performed in accordance with national guidelines for the care and use of laboratory animals and with the approval of the Institutional Committee for Animal Research.
Human lncRNA Microarray
Various cell lines (three normoxia-induced GC cell lines and three corresponding hypoxia-induced GC cell lines) were used for human lncRNA microarray analysis. Briefly, total RNA was extracted using TRIzol reagent (Invitrogen, Carlsbad, CA) and quantified using a NanoDrop ND-1000. The RNA integrity was assessed using standard denaturing agarose gel electrophoresis [25] . Approximately 5 μg total RNA from each sample was used to synthesize doublestranded cDNA, which was labeled and hybridiszd to the 12x135K Human lncRNA Expression Microarray (Arraystar, Rockville, MD). After hybridization and washing, array scanning was performed with an Axon GenePix 4000B microarray scanner. The acquired array images were analyzed with NimbleScan software (version 2.5). The expression data were normalized via quantile normalization and using the RMA algorithm included in the software. Differentially expressed lncRNAs and mRNAs were identified through fold-change filtering. Finally, hierarchical clustering was performed to show the differential lncRNA and mRNA expression pattern among samples.
Clinical Samples
Twenty pairs of human primary GC and matched noncancerous adjacent gastric tissues were collected at Xijing Hospital, Xi'an, China. Clinicopathologic features, including sex, age, tumor differentiation, tumor stage, and distant metastasis, are listed in Supplementary Table 2. All tissue samples were freshly frozen at − 80°C. Total RNA from the frozen tissues was isolated with TRIzol reagent according to the manufacturer's instructions.
Lentivirus Infection and Construction of Stable Cell Lines with Downregulated lncRNA-AK058003
To observe the effects of AK058003 knockdown on invasion and metastasis in vivo and in vitro, four different small interfering RNAs (siRNAs) that targeted AK058003 RNA and a scrambled siRNA control were generously provided by GenePharma (Shanghai, China). The four siRNAs were transfected into SGC7901 and MKN45 cells using Lipofectamine 2000 (Invitrogen) following the manufacturer's protocol. Twenty-four hours after transfection, AK058003 expression levels were measured through reverse transcriptase polymerase chain reaction (RT-PCR), and we found that siRNA-AK1 with the sequence 5'-CCACCAGUUACCUGCAAUATT-3' (sense) and 5'-UAUUGCAGGUAACUGGUGGTT-3' (antisense) and siRNA-AK2 with the sequence 5'-GGAACAAAGAUGGUUUCUATT-3' (sense) and 5'-UAGAAACCAUCUUUGUUCCTT-3' (antisense) yielded the highest degree of AK058003 knockdown. Then, we designed and synthesized AK058003-targeting sequence and inserted this sequence into a Supersilencing Vector (GenePharma, Shanghai, China). An unrelated sequence lentiviral vector was used as a negative control. SGC7901 and MKN45 cells were then plated into six-well plates and allowed to adhere for 24 hours. Next, the lentivirus was transfected according to the manufacturer's instructions. Stably transfected cells were selected with puromycin (Sigma-Aldrich, St. Louis, MO) and confirmed through fluorescence microscopy and RT-PCR.
Oligonucleotide Construction siRNAs targeting SNCG were synthesized by GeneChem (Shanghai, China), and a scrambled siRNA control was used as a negative control (provided by GeneChem). The sequence for the SNCG siRNA was 5'-CCAAGGAGAATGTTGTACA-3'. The cells were transfected using Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions.
Plasmid Construction
The full length of SNCG was amplified (forward primer: 5'-G A T A T G A A T T C G C C A C C A T G G A T G T C T T C A A GAAGGGCTTCTCC-3'; reverse primer: 5'-GTATCGGATCCC TAGTCTCCCCCACTCTGG-3') and then cloned into the pEX-2 vector. After digestion with EcoRI and BamHI, the correctness of the construct was confirmed by sequencing. An empty vector was used as a negative control.
In Vitro Migration and Invasion Assays
For transwell migration assays, 5×10 4 cells in serum-free RPMI 1640 medium were added to the upper chamber of each insert (BD Biosciences, Franklin Lakes, NJ). For invasion assays, the chamber inserts were coated with 50 mg/l Matrigel (BD Biosciences, San Jose, CA). After 4 to 5 hours of incubation at 37°C, 1×10 5 cells in serumfree RPMI-1640 medium were added to the upper chamber. In both assays, medium supplemented with serum was used as a chemoattractant in the lower chamber. After incubation in a normoxia (37°C and 5% CO 2 ) or hypoxia (37°C, 1% O 2 , 5% CO 2 , and 94% N 2 ) chamber for 24 or 48 hours, the cells on the upper surface were removed, and the cells on the lower surface of the membrane were fixed in 100% methanol for 15 minutes, air dried, stained with 0.1% crystal violet, and counted under a microscope (Olympus Corp., Tokyo, Japan) to calculate relative numbers. Nine random fields were analyzed per insert. Each experiment was conducted in triplicate in three independent experiments.
High-Content Screening Assay
Briefly, 5×10 3 cells were plated into each well of a 96-well plate and incubated at 37°C. After 24 hours, the culture medium was replaced with serum-free RPMI 1640 medium, and the cells were cultured for an additional 24 hours. The cells were then washed twice with ice-cold phosphate-buffered saline (PBS) and stained with Hoechst 33342 for 15 minutes in an incubator. The cells were subsequently washed twice with ice-cold PBS, and culture medium was added to each well. Cell motility was detected with a Cellomics ArrayScan VTI HCS (Thermo Scientific, Waltham, MA) according to the manufacturer's instructions (five replicate wells per group).
Wound-Healing Assays
SGC7901-siAK or SGC7901-Scr and MKN45-siAK or MKN45-Scr cells were seeded in six-well plates and incubated until 90% confluence in serum-free medium before wounding. A 200-μl tip was used to make a vertical wound, and the cells were then washed three times with PBS to remove cell debris. Cell migration into the wounded area was monitored by microscopy at the designated times.
In Vivo Metastasis Assays
Nude mice were purchased from the Experimental Animal Center of the Fourth Military Medical University. For in vivo metastasis assays, 2×10 6 SGC7901 and MKN45 cells infected with a lentivirus containing AK058003 siRNA and a negative control were suspended in 0.2 ml PBS and injected into the tail vein of each mouse. After 6 weeks, the mice were sacrificed, and their tumor nodules were counted under a stereomicroscope (Olympus). The tumor tissues derived from various organs were then dissected and histologically examined. Each tumor cell line was injected into 10 mice.
Bisulfite Sequencing PCR Analyses
Genomic DNA was extracted from GC cells with the QIAamp DNA Mini Kit (Qiagen, Valencia, CA) and subjected to bisulfite modification using an EpiTect Bisulfite kit (Qiagen) according to the manufacturer's protocol. We used Methyl Primer Express v1.0 to design primers on bisulfite-treated DNA.The primer is forward: 5'-GTTGTTTTGGGA TAGGGGTT-3' and reverse: 5'-CCRCAAACAAAAAAATACAAA-3'. PCR was performed in a final volume of 25 ml containing ddH 2 O 19.5μl, 10× PCR buffer 2.5μl, dNTP Mix 0.5μl, 0.5μl of each primer, 0.5μl rTaq, and 1μl DNA. PCR was carried out at 94°C for 5 minutes; 40 cycles at 94°C for 30 seconds, 58°C for 30 seconds, and 72°C for 30 seconds; and finally 72°C for 10 minutes. The PCR product was ligated into T Vector. After transformation, individual colonies were picked, and the insert was sequenced and analyzed by BiQ_Analyzer.
Statistical Analyses
The SPSS 12.0 program (SPSS Inc., Chicago, IL) was used for statistical analyses. The data are presented as the mean±standard error for at least three independent experiments. The differences between groups were analyzed using Student's t test when comparing only two groups or one-way analysis of variance when comparing more than two groups. The chi-square test was used to analyze the relationship between SNCG expression and various clinicopathologic characteristics. AK058003 and SNCG expression levels in clinical GC tissues and corresponding adjacent nontumorous tissues were compared using the Wilcoxon signed-rank test. Correlations between AK058003 and SNCG expression in tissue specimens were explored using Pearson's correlation. P b .05 was considered significant.
A detailed description of the materials and methods used in this study can be found in the Supporting Materials.
Results
lncRNA Expression Profile in Hypoxia-Induced GC Cells
To examine the overall impact of lncRNAs on hypoxic GC, we analyzed the expression profiles of lncRNAs and protein-coding RNAs in normoxia-induced and hypoxia-induced GC cells using microarray analysis. Scatter and volcano plots are shown in Figure S1 . Hierarchical clustering showed the differential lncRNA and proteincoding RNA expression profiles between normoxia-induced and hypoxia-induced GC cells ( Figure 1 , A and B). We set a threshold of a fold change N 1.5, P b .05, and found that 84 lncRNAs were upregulated and 70 were downregulated in all hypoxia-induced GC cells compared with normoxia-induced GC cells ( Figure 1 , C and D; Supplementary Tables 3 and 4 ). This finding indicated that the lncRNA expression profiles differed between the two groups.
To validate the microarray findings, we randomly selected six lncRNAs from the differentially expressed lncRNAs with a fold change N 3 and analyzed their expression through real-time PCR with hypoxia-induced GC cells (after 24 hours in 1% O 2 for the SGC7901, MKN45, and MKN28 GC cells) relative to normoxiainduced GC cells. The expression of most lncRNAs was consistent with the microarray results ( Figure S2, Supplementary Table 1 ), indicating that a set of lncRNAs is frequently aberrantly expressed in hypoxia-induced GC cells.
Newly Identified AK058003 Frequently Upregulated in GC and Induced by Hypoxia in GC Cells
Among the differentially expressed lncRNAs among hypoxiainduced GC cells and normoxia-induced GC cells, we were particularly interested in lncRNA-AK058003 because its expression increased approximately 6.20±1.65-fold upon hypoxia treatment in all three cell lines. Thus, we studied the role of AK058003, which is an intronic antisense lncRNA.
Given that AK058003 is induced by hypoxia in GC cells, we next sought to determine whether AK058003 could be induced by hypoxia at different exposure times (after 4, 8, 16, 24 , and 48 hours in 1% O 2 ) in GC cells. We found that AK058003 was induced under hypoxia, with the most robust induction observed after 16 hours in 1% O 2 for SGC7901 cells, 24 hours in 1% O 2 for MKN45 cells, and 48 hours in 1% O 2 for MKN28 cells (Figure 2, A-C) . The results suggest that AK058003 can indeed be regulated by hypoxia in GC cells; however, no significant difference was observed in expression after 4 or 8 hours in 1% O 2 .
Next, we assessed AK058003 expression in 95 pairs of human primary GC tissues and adjacent gastric tissues using quantitative RT-PCR to determine AK058003 expression in GC tissues. AK058003 expression was remarkably upregulated in GC tissues compared with noncancerous gastric tissues ( Figure 2D ), indicating that AK058003 upregulation is common in GC.
Effect of AK058003 on GC Cell Migration and Invasion and Hypoxia-Induced Migration and Invasion
The frequent AK058003 upregulation in hypoxic GC cells implies that AK058003 may play a role in hypoxia-induced GC. To test this hypothesis, the effects of reduced AK058003 expression on cell proliferation, migration, and invasion were investigated in two GC cell lines. Four different siRNA molecules were tested for their knockdown efficiencies, and the two most efficient of these molecules (siRNA-AK1 and siRNA-AK2) were selected for subsequent studies ( Figure 3, A and B) . We first established SGC7901 and MKN45 cell lines that stably repressed AK058003 expression by using an AK058003 siRNA-lentivirus (si-AK) vector, as verified by fluorescence microscopy ( Figure 3C ) and RT-PCR ( Figure 3D ). However, 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide and colony-forming assays showed that AK058003 downregulation did not significantly affect cell proliferation ( Figure S3 ).
To investigate whether AK058003 might have a role in hypoxiainduced metastasis, we first determined whether AK058003 affected normoxic GC cell migration and invasion. In transwell assays with or without Matrigel, SGC7901 and MKN45 cells with stable AK058003 knockdown showed significantly decreased migration and invasion compared with control cells (Figure 3, E and F) . Moreover, we examined cell motility in different groups under normoxia using high-content screening, which indicated that cell motility was reduced in AK058003 siRNA-lentivirus-treated cells compared with scrambled siRNA-treated cells ( Figure 3, G and H) . Taken together, these results indicate that although AK058003 did not affect GC cell growth, the lncRNA promoted migration and invasion.
Given that AK058003 can promote normoxic GC cell migration and invasion, we hypothesized that AK058003 might play a role in hypoxia-induced migration and invasion. To test this hypothesis, we first measured hypoxic GC cell migration and invasion. Hypoxia significantly increased the migration and invasion potential of SGC7901 and MKN45 cells (Figure 4, A-D) , which is consistent with previous reports [4, 5] . After transfection with a siRNA-lentivirus to decrease endogenous AK058003 expression, the hypoxia-induced migration and invasion of SGC7901 and MKN45 cells were dramatically diminished (Figure 4, A-D) . In addition, wound-healing assays showed that, under hypoxia, the cells more rapidly closed wounds (Figure 4 , E-H). However, after AK058003 knockdown in GC cells, wound healing was not significantly promoted under hypoxia compared with the control cells (Figure 4, E-H) .
To further explore the role of AK058003 in tumor invasion and metastasis in vivo, SGC7901 and MKN45 cells with stable AK058003 repression by an AK058003 siRNA-lentivirus or a scrambled siRNA vector-transfected control cells were delivered into nude mice via tail vein injection. We found that the number and size of lung and liver metastatic nodules dramatically decreased in mice administered cells with low AK058003 expression compared with the scrambled siRNA controls (Figure 4 , G-J). Taken together, these observations suggest that AK058003 is a positive metastatic regulator of GC.
SNCG an AK058003-Regulated Gene in GC
To explore the mechanism by which AK058003 promotes GC cell migration and invasion, we attempted to identify the lncRNA's potential target genes. Recent studies have reported that lncRNAs may function by positively or negatively regulating the expression of their neighboring protein-coding genes [14, 16, [26] [27] [28] .Thus, we retrieved the genomic locus information from the UCSC genome browser (http://genome.ucsc.edu/) and found that the tumor oncogene SNCG is located 8.6 kb downstream of AK058003, whereas another tumor suppressor gene, BMPR1A, is found 33.3 kb upstream of AK058003 ( Figure 5A ). To validate the association between the lncRNA AK058003 and BMPR1A or SNCG, we performed RT-PCR and western blotting using SGC7901 and MKN45 cells with AK058003 knockdown. BMPR1A expression was unchanged (data were not shown), whereas we observed significantly decreased SNCG levels in cells with low AK058003 expression compared with scrambled siRNA control cells ( Figure 5 , B-E) (This SNCG is a monomer; the molecular weight of the bands in the figure is approximately 16 kDa, predicted molecular weight: 13 kDa (Abcam, Cambridge, MA, Cat. #: ab52633)). Moreover, we showed that AK058003 suppressed SNCG mRNA and protein levels in GC cells and that there was a dose-dependent relationship between the expression of SNCG and AK058003 ( Figure 5 , B-E). These results suggest that SNCG is an AK058003-regulated gene in GC. We also found that SNCG was predominantly located in the cytoplasm of GC cells. Moreover, we found that SNCG expression was heterogeneous in tumor tissue; it was predominantly located in the center of the tumor but had almost negative expression in the stroma of GC tissues. There was little SNCG expression in paracancerous tissues. These results confirmed that SNCG protein levels in GC tissue were significantly higher than in paracancerous tissues. Additional analysis revealed that SNCG showed strong staining at primary sites from patients with metastatic GC compared with samples from patients with nonmetastatic GC ( Figure 6A ). Next, we analyzed the correlation between SNCG expression and the clinicopathologic parameters of GC patients. As shown in Supplementary Table 5, SNCG overexpression was associated with the depth of tumor invasion, the clinical tumor node metastasis stage, lymph node metastasis, and vascular invasion (P b .001 for all by the Mann-Whitney test). SNCG expression in GC patients did not correlate with age, sex, or cell differentiation. expression was assessed by real-time PCR. β-Actin was used as an internal control. The significant differences between samples were analyzed using the Wilcoxon signed-rank test (P = .002, n = 95).
We further investigated the correlation between AK058003 and SNCG expression in 95 clinical GC tissues and found that AK058003 and SNCG expression levels were positively correlated ( Figure 5F ). These observations indicate that SNCG is frequently upregulated in GC samples, possibly because of AK058003 overexpression.
Next, to investigate the potential mechanism by which AK058003 contributes to malignant behaviors of GC cells, we focused on DNA methylation of SNCG because lncRNAs are known to be involved in epigenetic regulation and DNA hypomethylation of SNCG has been confirmed in laryngeal cancer, including GC. Then, we performed bisulfite sequencing of cloned alleles over the region of − 169 to 81 of the SNCG exon1 CpG islands, which has been demonstrated to be involved in GC [29] . The results showed that SNCG CpG islands were densely hypomethylated in control SGC7901-si-Scr and MKN45-si-Scr cells, but GC cells transduced with AK058003 siRNA showed more methylated CpG dinucleotides ( Figure 5G ). Taken together, these results indicate that knockdown of AK058003 can downregulate the expression of SNCG in GC cells by regulating SNCG DNA methylation, which illustrates that SNCG may act as a downstream target of AK058003 in GC cells.
SNCG Mediates AK058003-induced Migration and Invasion of GC Cells
To further explore the biological function of SNCG in GC, siRNAs targeting SNCG were designed and transfected into SGC7901 and MKN45 cells. These siRNAs significantly decreased SNCG expression ( Figure 6C ). The migration and invasion of the two cell lines were significantly decreased by SNCG siRNA but not by the scrambled siRNA control (Figure 6, B and C) . To support these findings, we overexpressed SNCG in SGC7901 and MKN45 cells, which significantly increased cell migration and invasion ( Figure 6, D and E) .
If SNCG is indeed a functional gene of AK058003 in GC, then SNCG restoration in AK058003-downregulated GC cells should abrogate the effects of AK058003. To test this hypothesis, we introduced an SNCG expression vector into SGC7901 and MKN45 GC cells that had reduced AK058003 expression, restoring SNCG protein level ( Figure 6 , F-I). After SNCG restoration, the migration and invasion of SGC7901 and MKN45 cells that were previously inhibited by si-AK058003 significantly increased. These results indicate that SNCG is a functional gene of AK058003 in GC cells.
SNCG Regulation by AK058003 Mediates Hypoxia-Induced GC Metastasis
To determine whether SNCG is involved in AK058003-induced hypoxic GC cell metastasis, we first detected SNCG expression under hypoxia. The results showed that SNCG expression in GC cells increased under hypoxia compared with normoxia ( Figure 7 , A and B; upper panel). When AK058003 expression was downregulated in SGC7901 and MKN45 cells, the hypoxia-induced SNCG increase was abrogated ( Figure 7 , A and B; lower panel), indicating that SNCG overexpression was mediated by AK058003 upregulation under hypoxia. Moreover, transwell assays indicated that inhibiting SNCG expression promoted hypoxia-induced migration and invasion ( Figure 7, C-F) . To determine the function of SNCG in AK058003-induced GC metastasis under hypoxia, an SNCG expression vector and a scramble control were cotransfected into SGC7901 and MKN45 cells with stable AK058003 suppression. In transwell experiments, the impairment of the effects of siRNA-mediated AK058003 on hypoxiainduced GC cell migration and invasion was partially relieved by SNCG but not by the negative control (Figure 7 , G-J). Taken together, these results indicate that SNCG expression is increased by hypoxia and that SNCG upregulation by AK058003 mediates hypoxia-induced GC metastasis.
Discussion
Hypoxia is an important microenvironmental factor in nearly every solid tumor, including GC, and it is related to an increased risk of metastasis and invasion [30] . The contribution of hypoxia-induced signaling pathways to malignancy is of great interest [31, 32] . Our previous studies found that many protein-coding genes associated with hypoxia correlation with GC metastasis and invasion [4] [5] [6] . However, the exact mechanism in this process has not been thoroughly elucidated. Recently, mounting evidence suggests that the expression of many lncRNAs is altered in different types of human cancer [33] . Fu Yang et al. demonstrated that a hypoxic microenvironment suppresses lncRNA-LET, which was associated with HepatoCellular Carcinoma metastasis [10] . In another study, Fan Yang et al. found that lincRNAp21 is a hypoxia-responsive lncRNA and is essential for hypoxiaenhanced glycolysis [34] . However, whether lncRNA is also involved in the hypoxic GC remains uncharacterized. In this study, as a first attempt to investigate whether lncRNA expression is altered under hypoxic conditions, we first searched for potential hypoxia-responsive lncRNAs using lncRNA microarrays between hypoxia-induced GC cells and normoxia-induced GC cells. The results showed that hypoxia alters lncRNA expression and indicate that hypoxic GC may have specific lncRNA profiles. We then selected six lncRNAs from the differentially expressed lncRNAs with a fold change N 3 and performed a quantitative RT-PCR to examine these lncRNAs' expression levels in GC cells under both normoxic and hypoxic conditions. Of these six lncRNAs, only AK058003, which is a 1197-bp transcript and is located in the chromosome 10q22 on the forward strand, was strongly induced by hypoxia in three GC cells and upregulated in GC samples. In addition, lncRNA-AK058003 was induced by hypoxia at a time-dependent manner in different GC cells. These data indicate the specificity of lncRNA-AK058003 in hypoxic induction. Moreover, we found that AK058003 mediated hypoxia-induced GC migration and invasion in vitro and in vivo. To our knowledge, this study is the first report demonstrating that an lncRNA enhances GC cell migration and invasion under hypoxia. Thus, our results suggest that lncRNA-AK058003 may not only act as a tumor hypoxia marker or adjust cells to hypoxic stress in tumors but may also have a biological role in tumor malignancy and metastasis.
However, the mechanism of lncRNAs in hypoxic cancer has not been thoroughly elucidated. Several reports have demonstrated that the expression levels of certain lncRNAs are correlated with the nearest protein-coding genes and that these lncRNAs may have either a positive [26, 35] or negative [14, 16] effect on gene expression. Accordingly, we were interested in the genes surrounding AK058003. We then retrieved the genomic locus information and found that the SNCG gene, which is a prometastatic oncogene, is only approximately 8.6 kb downstream from the AK058003 gene.
SNCG was first discovered by direct differential cDNA sequencing in breast cancer samples [36] and can promote breast cancer metastasis and invasion [37] . Certain studies have revealed a strong correlation between SNCG expression in primary tumors and distant metastasis in many cancer types, including liver, esophageal, colon, gastric, lung, prostate, and cervical cancers [38] . Furthermore, SNCG expression may be related to the tumor microenvironment [39] . In our study, we found that SNCG expression is increased in GC samples, particularly in metastatic tissues, and promotes GC metastasis. After analyzing the relationship between SNCG expression and the clinicopathologic factors of GC patients, we found a significant association between SNCG expression and the depth of tumor invasion, clinical tumor node metastasis stage, lymph node metastasis, and vascular invasion. Moreover, we observed that SNCG was also involved in hypoxia-induced GC metastasis. Furthermore, we found that the SNCG mRNA levels were positively correlated with the expression of AK058003 in 95 pairs of clinical GC samples. Accordingly, we have found that AK058003 knockdown could downregulate SNCG expression at the mRNA and protein levels in a dose-dependent manner. These data demonstrated that SNCG downregulation is at least partly caused by AK058003 downregulation in GC.
However, the mechanism of AK058003 regulation of SNCG is still unknown. Surgucheva et al. demonstrated that mature miRs repress protein expression primarily through base pairing of a seed region with the 3'-UTR of SNCG [40] . Furthermore, several studies reported that SNCG expression is activated by demethylation of the SNCG CpG island in the development of cancer, including GC [29, 41, 42 ]. In another study, H. Liu et al. found that cigarette smoke induces the demethylation and subsequent expression of SNCG gene in lung cancer cells through downregulation of DNA methyltransferase 3B [43] . Recently, increasing evidence confirmed that lncRNA can regulate DNA methylation of protein-coding genes during the development of disease [22, 35, 44, 45] . For instance, in a recent paper published in Nature, Di Ruscio and colleagues reported that the lncRNA-ecCEBPA interacts with DNA methyltransferase 1, resulting in prevention of CEBPA gene methylation and robust CEBPA mRNA production [35] . Wei Li et al. demonstrated that linc-POU3F3 promotes cell viability and proliferation in esophageal squamous cell carcinoma cell levels and altered linc-POU3F3 levels could drive the methylation of the POU3F3 gene, which is located in the downstream of 4 kb from the linc-POU3F3 [46] . Because SNCG gene is subject to silencing by DNA methylation, we assessed whether depletion of AK058003 resulted in changes in DNA methylation of SNCG. Interestingly, using Bisulfite sequencing PCR assays, we observed a robust increase in levels of DNA methylation of SNCG following the depletion of AK058003.
Furthermore, we have observed that SNCG overexpression was mediated by AK058003 upregulation under hypoxia and that the SNCG upregulation by AK058003 mediates hypoxia-induced GC metastasis. This finding indicated that hypoxia/AK058003/SNCG is a new signaling pathway involved in hypoxia-induced GC metastasis and invasion. Restoration of SNCG significantly increased the GC cell migration and invasiveness inhibited by AK058003 knockdown under hypoxia. (A, B) SNCG protein levels in SGC7901 and MKN45 cells. The cells were transfected with an AK058003 siRNA-lentivirus (si-AK) or a scrambled siRNA control (si-Scr) and then exposed to hypoxia after transfection. The cells were then collected and subjected to Western blot analysis at specific time points, as indicated. β-Actin served as an internal control. (C, D, E, F) Transwell migration and invasion assays of SGC7901-si-Scr and SGC7901-si-SNCG cells (C, D) and MKN45-si-Scr and MKN45-si-SNCG cells (E, F) were performed under normoxic or hypoxic conditions. SNCG protein levels were determined by Western blot assays as well (at bottom of D and F). (G, H, I, J) Transwell migration and invasion assays of SGC7901 (G, H) and MKN45 (I, J) cells were performed after transfection with an AK058003 siRNAlentivirus (si-AK), SNCG expression vector, or a scrambled siRNA control (si-Scr) under normoxic or hypoxic conditions. SNCG protein levels were determined through Western blot assays as well (at bottom of H and J). In all panels, the results are representative of at least three independent experiments.
In conclusion, our results indicated that lncRNA-AK058003 expression is frequently increased in hypoxic GC and promotes hypoxia-induced GC metastasis and invasion. SNCG, a metastasisassociated gene in cancer that is involved in hypoxia-induced GC metastasis, was identified as a functional gene that was regulated by AK058003 through DNA demethylation. SNCG upregulation by AK058003 mediates hypoxia-induced GC cell migration and invasion. Further study will explore the exact mechanism of SNCG DNA demethylation that is induced by AK058003. In summary, this finding suggests that the hypoxia/AK058003/SNCG pathway may contribute to the development of new anticancer therapeutics directed against hypoxic tumor targets.
Supplementary data to this article can be found online at http://dx. doi.org/10.1016/j.neo.2014.10.008.
